Table 3. Details of the production of stability samples for Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate (Benchtop and Long-Term) .
|
Preparations of spiked plasma – Doravirine and Tenofovir Disoproxil Fumarate Benchtop and Long-Term Stability study | |||||
|
Concentration of stock in µg/mL |
Stock volume (mL) |
Plasma volume (mL) |
Final volume (mL) |
Final concentration (ng/mL) |
Details |
|
0.08 |
0.1 |
0.9 |
1 |
7.4 |
LQC (Old) |
|
0.08 |
0.1 |
0.9 |
1 |
7.4 |
LQC (Fresh) |
|
18.00 |
0.1 |
0.9 |
1 |
900 |
HQC (Old) |
|
18.00 |
0.1 |
0.9 |
1 |
900 |
HQC (Fresh) |
HQC: High-Quality Control, LQC: Low-Quality Control